According to the report, the hypodermic needles market size was valued at US$ 2 Bn in 2020 and is expected to reach US$ 4 billion by 2030, poised to grow at a noteworthy CAGR of 6.1% from 2021 to 2030.
Hypodermic Needles Market (By Type: Safety Needles, Non-safety Needles; By Application: Drug Delivery and Others; By End User: Hospitals, Cancer Treatment Centers, Dermatology Clinics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030
Get Sample Copy of This Report (Including TOC, List of Tables & Figures, and Chart)@ https://www.visionresearchreports.com/report/sample/38749
Hypodermic needles play important role in research requiring sterile conditions. A hypodermic needle significantly reduces contamination during inoculation of a sterile substrate. Different types of hypodermic needles used for drug delivery and other purposes are safety needles and non-safety needles. A hypodermic (hypo – under, dermic – the skin) needle is a hollow needle commonly used with a syringe to inject substances into the body or extract fluids from it. It could also be used to take liquid samples from the body; for instance, taking blood from a vein in venipuncture. A hypodermic needle provides rapid delivery of liquids. It is used when the injected substance cannot be ingested orally, as it would not be absorbed, and with insulin, or as it would harm the liver.
The global hypodermic needles market is driven by rise in prevalence of chronic diseases and enforcement of legislation mandating the use of safety syringes.
Surge in cases of chronic diseases, including cancer and cardiovascular disorders, is a key driver of the global hypodermic needles market. Prevalence of chronic diseases is rising due to sedentary lifestyles, poor eating patterns, obesity, and high tobacco & alcohol consumption. According to the American Heart Association’s 2019 study, cardiovascular disease (CVD) is the leading cause of death, accounting for over 17.6 million deaths in 2016. The number is expected to rise to 23.6 million by 2030.
Increase in demand for vaccines is another key factor to boost the growth of the global hypodermic needles market over the next few years. Moreover, rise in cases of infectious diseases contributes to the growth of the global market. Launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases fuels the growth of the market.
Rise in Prevalence of Chronic Diseases, Enforcement of Legislation Mandating Use of Safety Syringes to Drive Global Market
The rise in prevalence of major chronic diseases such as cancer, cardiovascular diseases, and diabetes is anticipated to drive the demand for hypodermic needles in the near future. According to the World Health Organization, cancer is a leading cause of death globally, accounting for nearly 10 million deaths in 2020. According to the International Diabetes Federation’s 2019 report, the number of people living with diabetes is expected to increase from 463 million in 2019 to nearly 578.4 million in 2030. Enforcement of legislation in countries of North America mandating the use of safety syringes and rise in healthcare cost propel the hypodermic needles market in the region. The hypodermic needles market is driven by factors such as increase in incidence of needlestick injuries, improvement in safety mechanism, and favorable government initiatives.
In terms of type, the global hypodermic needles market has been bifurcated into safety needles and non-safety needles. The safety needles segment dominated the global hypodermic needles market in 2020 and the trend is expected to continue during the forecast period. The safety needles segment is likely to be driven by increase in cases of blood-borne diseases, active government participation to implement stringent regulations, surge in demand for injectable drugs & vaccines, and untapped potential.
Based on application, the global hypodermic needles market has been classified into drug delivery and others. The drug delivery segment has been split into chemotherapy, spinal/ epidural infusion, plastic surgery, and others. A hypodermic needle is useful to deliver certain medications that cannot be delivered orally due to vomiting. These factors are projected to fuel the growth of the drug delivery segment during the forecast period.
In terms of end user, the global hypodermic needles market has been divided into hospitals, cancer treatments centers, dermatology clinics, and others. The hospitals segment led the global hypodermic needles market in terms of revenue in 2020 and the trend is anticipated to continue during the forecast period. The segment’s dominance can be attributed to large patient base and high adoption of hypodermic needles in hospitals.
In terms of region, the global hypodermic needles market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global hypodermic needles market in 2020, followed by Europe. North America’s large market share can be ascribed to the launch of technologically advanced products, rise in awareness about hypodermic needles, and presence of major players.
The hypodermic needles market in Asia Pacific is expected to expand at a high CAGR from 2021 to 2030. This can be attributed to the presence of developing countries with commercial hubs, expansion of business organizations, improvement healthcare infrastructure, and increase in investments by companies.
The global hypodermic needles market is fragmented due to the presence of a large number of leading players. Key players operating in the global hypodermic needles market include Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic, Smiths Medical, Cardinal Health, Novo Nordisk, Medline Industries, Inc., Terumo Medical Corporation, Cadence Science, and Exelint International, Co.
Report Scope of the Hypodermic Needles Market
|Market Size||US$ 4 Billion by 2030|
|Growth Rate||CAGR of 6.1% From 2021 to 2030|
|Forecast Period||2021 to 2030|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Companies Mentioned||Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic, Smiths Medical, Cardinal Health, Novo Nordisk, Medline Industries, Inc., Terumo Medical Corporation, Cadence Science, and Exelint International, Co.|
- Safety Needles
- Non-safety Needles
- Drug Delivery
- Spinal/ Epidural Infusion
- Plastic Surgery
- Drug Delivery
By End User
- Cancer Treatment Centers
- Dermatology Clinics
- North America
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- North America
Browse complete table of contents at@ https://www.visionresearchreports.com/hypodermic-needles-market/toc/38749
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2021) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Buy This Premium Research Report, click here@ https://www.visionresearchreports.com/report/cart/38749 or call: +1 9197 992 333